ABOUT THE PRODUCT
Emcitate® (tiratricol) is our lead product candidate, a treatment for MCT8 deficiency (Allan-Herndon-Dudley syndrome).
Information is owner-confirmed
Last updated 2 weeks ago
Price range
N/A
ABOUT THE PRODUCT
Information is owner-confirmed
Last updated 2 weeks ago
